Allow, a global company private equity, announced the sale of the group Althea, European leader in the integrated management of technologies for the healthcare sector, to a consortium formed by F2i, the largest independent infrastructure fund manager in Italy e DWS Infrastrutture, one of the world's leading investors in the infrastructure sector, through its subsidiary Intermedical. The advisors of the operation are Rothschild & Co, EY, Giliberti and Triscornia e Associati.
With the transition to F2i and Dws, Althea aims to modernize biomedical infrastructure, reinforcing its role as a partner of hospitals, says a statement.
Althea, interface with hospital facilities for medical equipment
Althea serves beyond today 2.700 structures sanitary in 18 CountriesOver 3.000 employees managing over 1,4 million medical devices.
It was founded in 2014 with the merger of Mesa in Switzerland and Asteral in the United Kingdom, followed by the acquisitions of the IBSL group and TBS in Italy, with the aim of creating a leading independent group in services to medical equipment, enabling hospitals to benefit from an integrated, vendor neutral and high quality service at an affordable cost.
Althea has also brought together highly qualified medical services companies across Europe to build a platform with unique expertise and differentiated positioning to serve hospitals and clinics, the statement said.
"I am convinced that F2i is the perfect partner to accompany the Group in the next chapter of our growth, which will lead Althea to further strengthen its role as a partner of hospital structures through investments aimed at modernizing the biomedical infrastructures serving the national hospital system" he said Alessandro Dogliani, Chief Executive Officer of Althea after thanking Permira "for the development path of the last few years".
Through the investments of the Permira Funds, the company has seen 14 acquisitions in the sector, including the 'takeprivate' operation of the listed TBS group (2017), the integration of central functions at group level, the transformation into a platform, becoming the first European player and a strategic partner for healthcare professionals.
